Statement Of Financial Position [Abstract]

Pharming Group N.V. - Filing #1859781

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
13,222,000 USD
12,226,000 USD
9,591,000 USD
Right-of-use assets
19,943,000 USD
9,427,000 USD
6,704,000 USD
Intangible assets other than goodwill
83,834,000 USD
94,083,000 USD
79,403,000 USD
Investments accounted for using equity method
7,201,000 USD
7,118,000 USD
6,177,000 USD
Deferred tax assets
21,216,000 USD
31,877,000 USD
32,061,000 USD
Cash and cash equivalents
191,924,000 USD
205,159,000 USD
74,348,000 USD
Assets
397,315,000 USD
418,453,000 USD
255,915,000 USD
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
7,429,000 USD
7,312,000 USD
7,226,000 USD
Retained earnings
273,167,000 USD
295,621,000 USD
340,715,000 USD
Share premium
455,254,000 USD
447,130,000 USD
441,951,000 USD
Other reserves
3,400,000 USD
24,614,000 USD
8,926,000 USD
Equity
273,167,000 USD
2,283,000 USD
192,916,000 USD
1,316,000 USD
402,000 USD
455,254,000 USD
3,965,000 USD
7,429,000 USD
295,621,000 USD
USD
7,312,000 USD
622,000 USD
19,037,000 USD
447,130,000 USD
4,955,000 USD
183,435,000 USD
USD
4,081,000 USD
441,951,000 USD
117,388,000 USD
340,715,000 USD
USD
4,845,000 USD
7,226,000 USD
Equity and liabilities
397,315,000 USD
418,453,000 USD
255,915,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.